SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma to acquire Innovcare Lifesciences

22 Jun 2026 Evaluate

Sun Pharmaceutical Industries has entered into an agreement to acquire 100% outstanding shares of Innovcare Lifesciences. The deal is worth around Rs 271.2 crore. This strategic investment is aimed at strengthening the product portfolio of the company. The transaction is expected to be completed on or before July 31, 2026.

Innovcare Lifesciences is a company based in Mumbai and engaged in the business of marketing, distribution and sale of pharmaceutical drugs, nutraceutical and cosmeceutical products.  

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma. Inds. Share Price

1874.70 6.90 (0.37%)
24-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1874.70
Dr. Reddys Labs. 1328.35
Cipla 1437.35
Zydus Lifesciences 1099.10
Lupin 2367.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: